The MAP Japan study presented in this issue confirms Micra lead less pacemakers safety, especially for high-risk Japanese patients.
By Eiichi Watanabe
https://t.co/dNAaxrahNS
#circ_j #CardioTwitter https://t.co/BC8kJtCvI2
The MAP Japan study presented in this issue confirms Micra lead less pacemakers safety, especially for high-risk Japanese patients.
By Eiichi Watanabe
https://t.co/dNAaxrahNS
#circ_j #CardioTwitter https://t.co/9VMvq7qBZW